Q32 Bio Inc. (QTTB)
Q32 Bio Inc. (QTTB) is a healthcare company (biotechnology) based in the United States. The share price is $8.56, up 3.20% on the day, which values the company at $256M. Price as of 17 Nov 2026, 18:25 UTC, from Yahoo Finance.
Key facts
- Share price
- $8.56+3.20% today
- Market value
- $256M
- P/E ratio
- 2.4×last 12 months
- Funk Score
- 76/100
- 200-week average
- $14.1740% below
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Q32 Bio Inc. in more detail
QTTB trades at 2.4× its last twelve months' earnings, -8.4× next year's expected earnings, 4.8× sales. It sits 40% below its 200-week average of $14.17.
Over the last five fiscal years Q32 Bio Inc. has compounded revenue 81.9% a year. Its Funk Score is 76 out of 100 (financial strength 8.7, profitability 6.2, growth 7.8, each out of 10).
In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Weak Piotroski score; Profit is not turning into cash.
1 of the superinvestors tracked here hold QTTB, including Peter Kolchinsky (0.3% of the portfolio).
Superinvestors holding QTTB
1 of the investors tracked here report a position in their latest 13F filing.
- Peter Kolchinsky RA Capital Management0.26% of portfolio · $29.7M · new · Q2 2026
Q32 Bio Inc. (QTTB): questions and answers
What is QTTB's P/E ratio?
Q32 Bio Inc. trades at 2.4× its last twelve months' earnings and -8.4× next year's expected earnings.
What is Q32 Bio Inc.'s market cap?
Q32 Bio Inc. is valued at $256M at a share price of $8.56.
Is QTTB above its 200-week moving average?
No. QTTB is 39.6% below its 200-week average of $14.17. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Q32 Bio Inc. growing?
Over the last five fiscal years Q32 Bio Inc.'s revenue grew 81.9% a year.
Does QTTB pay a dividend?
Q32 Bio Inc. does not currently pay a regular dividend.
Which famous investors own QTTB?
In their latest quarterly filings, Peter Kolchinsky (0.3% of the portfolio) hold QTTB. These filings are published up to 45 days after each quarter ends, so positions may have changed since.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Q32 Bio Inc. (QTTB) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/QTTB
Underlying data: Yahoo Finance; company filings with the SEC.